期刊文献+

硝基苯并环磷酰胺化合物的还原及其细胞增殖抑制活性的研究

The study on reduction and antiproliferation activity of nitrobenzocyclophosphamidesin cell culture
下载PDF
导出
摘要 目的对以基因导向酶前药治疗策略为目的所合成的硝基环磷酰胺类化合物还原性及细胞增殖抑制作用进行研究。方法以NaBH4化学还原和E .coli硝基还原酶进行还原性研究;以E .coli硝基还原酶(T116 )和人醌氧化还原酶(NQO1F179)表达细胞(V79)进行细胞增殖抑制作用研究。结果以氧原子与硝基苯环相连的环磷酰6b和6d对E .coli硝基还原酶表达细胞增殖毒性的选择性在30倍以上。 PurposeTo make efforts to obtain potential anticancer prodrugs for gene-directed enzyme prodrug therapy using E.coli nitroreductase.MethodsThe reductive activation and antiproliferative activity in cell culture of four benzocyclophosphamides 6a-d were tested.Results6b and 6d,both with a benzylic oxygen in the phosphorinane ring para to the nitro group,showed a modest 30 fold enhanced cyctotoxicity in E. coli nitroreductase-expressing cells.ConclusionThese results suggest that compounds 6b and 6d represent a new structure protype for reduction and a lead for further modification in the development of better analogues with improved selective toxicity to be used in gene-directed enzyme prodrug therapy.
出处 《中国生化药物杂志》 CAS CSCD 2005年第1期9-11,共3页 Chinese Journal of Biochemical Pharmaceutics
基金 国家自然科学基金资助项目 (No .3 0 0 70 893 )
关键词 基因导向酶前药 苯并环磷酰胺 E.coli硝基还原酶 抗细胞增殖活性 gene-directed enzyme prodrug benzocyclophosphamides E.coli nitroreductase antiproliferation
  • 相关文献

参考文献3

  • 1刘宗英 汤雁波 李艳萍 等.导向治疗前列腺癌药物的合成与筛选Ⅰ:取代苯并环磷酰胺化合物的合成研究[A]..中国医学科学院中国协和医科大学科学年会学术论文集[C].北京:中国协和医科大学出版社,2002.618-621.
  • 2Bridgewater J, Minton NP, Michael NP, et al. Expression of bacterial nitroreductase in mammalian cells renders them selectively sensitive to kiling by CB 1954[J]. Eur J Cancer, 1995,31:2362-2370.
  • 3Anlezark GM, Melton RC, Sherwood RF, et al. The bioactivitation of 5-(aziridin-1-yl)-2,4- dinitrobenzamide(CB1954)-I. Purification and properties of a nitroreductase enzyme from Escherichia coli-a potential enzyme for antibody directed enzyme prodrug therapy (ADEPT) [ J ].Biochem Pharmacol, 1992,44: 2289-2295.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部